167 related articles for article (PubMed ID: 33413414)
1. "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.
de Vere Hunt I; Kilgour JM; Danby R; Peniket A; Matin RN
Health Qual Life Outcomes; 2021 Jan; 19(1):11. PubMed ID: 33413414
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
3. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
4. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
6. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
[TBL] [Abstract][Full Text] [Related]
7. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
[TBL] [Abstract][Full Text] [Related]
8. What else do I need to worry about when treating graft-versus-host disease?
El-Jawahri A
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):655-661. PubMed ID: 34889363
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
10. What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.
Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I
Biol Blood Marrow Transplant; 2016 Apr; 22(4):731-743. PubMed ID: 26746819
[TBL] [Abstract][Full Text] [Related]
11. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
[TBL] [Abstract][Full Text] [Related]
12. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
13. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in 244 recipients of allogeneic bone marrow transplantation.
Chiodi S; Spinelli S; Ravera G; Petti AR; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
Br J Haematol; 2000 Sep; 110(3):614-9. PubMed ID: 10997973
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease.
Kilgour JM; Wali G; Gibbons E; Scherwath A; Barata Badiella A; Peniket A; Schoemans H; Matin RN;
Biol Blood Marrow Transplant; 2020 May; 26(5):e113-e127. PubMed ID: 32028026
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.
Cusatis RN; Tecca HR; D'Souza A; Shaw BE; Flynn KE
Cancer; 2020 Jun; 126(11):2679-2686. PubMed ID: 32154926
[TBL] [Abstract][Full Text] [Related]
20. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Blood; 1998 Feb; 91(3):756-63. PubMed ID: 9446633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
